Harrisvaccines Inc. has won the second annual DuPont Pioneer innovationLEADER of the Year award. The award recognizes an individual or organization for originality, leadership and impact.

Harrisvaccines will be honored at the free unveiling party for the 2016 edition of innovationIOWA magazine on Tuesday from 5 to 7 p.m. at Workiva in Ames.

Despite being founded only 10 years ago, Harrisvaccines is revolutionizing animal health vaccines. The company generates state-of-the-art vaccines in the swine, poultry, bovine, equine, companion animal and aquaculture industry segments.

With about 40 employees, Harrisvaccines has become an emerging leader in the development and commercialization of rapid-response vaccines. These vaccines help protect against newer or difficult-to-control disease outbreaks that threaten livestock and human health. The company also ships vaccines to other countries, including Canada, Mexico, the Dominican Republic and the Philippines.

Harrisvaccines made headlines in 2014 for its work on an Ebola vaccine but gained prominence for its groundbreaking vaccine for PEDv, a lethal swine disease that was first diagnosed in the United States in April 2013. The company was most recently recognized for developing a vaccine for the avian flu.

In October 2015, Ames-based Harrisvaccines was awarded one of two contracts from the U.S. Department of Agriculture's Animal and Plant Health Inspection Service to provide 48 million doses of the avian flu H5 vaccine for its stockpile.